Janus kinase inhibitor use and incident dry eye disease in rheumatoid arthritis: a real-world cohort study

PurposeTo examine the association between systemic Janus kinase (JAK) inhibitor use and the incidence of newly diagnosed dry eye disease (DED) in patients with rheumatoid arthritis (RA).MethodsThis multi-institutional retrospective cohort study used de-identified electronic health records from the U...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ching-Chieh Lin, Yang-Chi Lin, Renin Chang, Chun-Yu Lin, Jiunn-Liang Chen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-07-01
Series:	Frontiers in Immunology
Assuntos:	anti-inflammatory agent dry eye disease janus kinase inhibitor ocular surface rheumatoid arthritis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1871716/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!